...
机译:重新检查前列腺特异性抗原(PSA)密度:使用PSA密度定义最佳PSA范围和患者使用延长模板活组织检查预测前列腺癌
Department of Urology University of Miami Leonard M. Miller School of Medicine and Sylvester;
Department of Urology University of Miami Leonard M. Miller School of Medicine and Sylvester;
Department of Urology University of Miami Leonard M. Miller School of Medicine and Sylvester;
Department of Urology University of Miami Leonard M. Miller School of Medicine and Sylvester;
Department of Urology University of Miami Leonard M. Miller School of Medicine and Sylvester;
Department of Urology University of Miami Leonard M. Miller School of Medicine and Sylvester;
Department of Urology University of Miami Leonard M. Miller School of Medicine and Sylvester;
Department of Urology University of Miami Leonard M. Miller School of Medicine and Sylvester;
Department of Urology University of Miami Leonard M. Miller School of Medicine and Sylvester;
OPKO Diagnostics LLC;
Department of Urology University of Miami Leonard M. Miller School of Medicine and Sylvester;
Department of Urology University of Miami Leonard M. Miller School of Medicine and Sylvester;
Department of Urology University of Miami Leonard M. Miller School of Medicine and Sylvester;
机译:重新检查前列腺特异性抗原(PSA)密度:使用PSA密度定义最佳PSA范围和患者使用延长模板活组织检查预测前列腺癌
机译:前列腺特异性抗原(PSA)密度,前列腺体积及其区调整后衍生物在预测PSA患者中预测前列腺癌的作用小于20.0ng / ml
机译:由于每单位肿瘤体积PSA分泌减少,前列腺特异性抗原(PSA)密度预测初始前列腺活检和前列腺切除术之间的Gleason评分升级的能力随肿瘤等级的增加而降低
机译:对前列腺特异性抗原(PSA)糖蛋白对健康和癌症样品的定性和定量研究
机译:前列腺癌和PSA检测:提供者与患者之间的沟通以及共同决策对国家筛查建议的影响。
机译:前列腺特异性抗原水平为4.0 ng / ml或更低的前列腺癌的前列腺特异性抗原(PSA)密度和游离PSA总比
机译:前列腺成像报告和数据系统的组合(PI-rads)得分和前列腺特异性抗原(PSA)密度预测前列腺活组织检查Naïve患者的活组织检查结果